Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients

NCT01344655 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Atimos®
DRUG: Serevent™
DRUG: Placebo

Sponsor

Chiesi Farmaceutici S.p.A.